ORAGENICS, INC. Revenues
ORAGENICS, INC. (OGEN) reported Revenues of $0 for the 3-month period ending 2018-12-31, per its 10-K filed 2019-03-29.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2019-03-29
- ORAGENICS, INC. revenues for the quarter ending 2018-12-31 was $0.00.
- ORAGENICS, INC. revenues for the quarter ending 2018-09-30 was $0.00.
- ORAGENICS, INC. revenues for the quarter ending 2018-06-30 was $0.00.
- ORAGENICS, INC. revenues for the quarter ending 2018-03-31 was $0.00.
- ORAGENICS, INC. revenues for fiscal 2014 was $939.93K, a 8.94% decline from fiscal 2013.
- ORAGENICS, INC. revenues for fiscal 2013 was $1.03M, a 22.49% decline from fiscal 2012.
- ORAGENICS, INC. revenues for fiscal 2012 was $1.33M, a 7.80% decline from fiscal 2011.
- ORAGENICS, INC. revenues for fiscal 2011 was $1.44M, a 10.35% increase from fiscal 2010.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-09-30 | $0.00 10-K · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 10-Q · filed 2018-11-13 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | $0.00 10-K · filed 2019-03-29 | $0.00 10-Q · filed 2018-08-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | $0.00 10-K · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 derived: sum of 3 quarters · filed 2019-03-29 | $0.00 derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-09-30 | $0.00 10-K · filed 2019-03-29 | $0.00 derived: sum of 2 quarters · filed 2019-03-29 | $0.00 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $0.00 10-K · filed 2019-03-29 | $0.00 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | $0.00 10-K · filed 2019-03-29 | |||
| 2015-12-31 | $240.23K 10-K · filed 2016-03-30 | $570.03K derived: sum of 2 quarters · filed 2016-03-30 | $812.07K derived: sum of 3 quarters · filed 2016-03-30 | $1.18M derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-09-30 | $329.80K 10-K · filed 2016-03-30 | $571.83K derived: sum of 2 quarters · filed 2016-03-30 | $935.61K derived: sum of 3 quarters · filed 2016-03-30 | $1.16M derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-06-30 | $242.04K 10-K · filed 2016-03-30 | $605.81K 10-Q · filed 2015-08-07 | $826.32K derived: sum of 3 quarters · filed 2016-03-30 | $1.03M derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-03-31 | $363.77K 10-K · filed 2016-03-30 | $584.28K derived: sum of 2 quarters · filed 2016-03-30 | $785.29K derived: sum of 3 quarters · filed 2016-03-30 | $1.09M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-12-31 | $220.50K 10-K · filed 2016-03-30 | $421.51K derived: sum of 2 quarters · filed 2016-03-30 | $725.27K derived: sum of 3 quarters · filed 2016-03-30 | $939.93K 10-K · filed 2015-02-27 |
| 2014-09-30 | $201.01K 10-K · filed 2016-03-30 | $504.76K derived: sum of 2 quarters · filed 2016-03-30 | $719.42K 10-Q · filed 2014-11-03 | $1.15M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | $303.75K 10-K · filed 2016-03-30 | $518.41K 10-Q · filed 2015-08-07 | $953.20K derived: sum of 3 quarters · filed 2016-03-30 | $1.21M derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | $214.66K 10-K · filed 2016-03-30 | $649.44K derived: sum of 2 quarters · filed 2016-03-30 | $902.82K derived: sum of 3 quarters · filed 2016-03-30 | $1.07M derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | $434.78K 10-K · filed 2015-02-27 | $688.16K derived: sum of 2 quarters · filed 2015-02-27 | $855.83K derived: sum of 3 quarters · filed 2015-02-27 | $1.03M 10-K · filed 2015-02-27 |
| 2013-09-30 | $253.37K 10-K · filed 2015-02-27 | $421.04K derived: sum of 2 quarters · filed 2015-02-27 | $597.45K 10-Q · filed 2014-11-03 | $1.03M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | $167.67K 10-K · filed 2015-02-27 | $344.07K 10-Q · filed 2014-08-07 | $774.66K derived: sum of 3 quarters · filed 2015-02-27 | $1.04M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | $176.41K 10-K · filed 2015-02-27 | $606.99K derived: sum of 2 quarters · filed 2015-02-27 | $871.24K derived: sum of 3 quarters · filed 2015-02-27 | $1.13M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $430.58K 10-K · filed 2014-02-28 | $694.83K derived: sum of 2 quarters · filed 2014-02-28 | $951.24K derived: sum of 3 quarters · filed 2014-02-28 | $1.33M 10-K · filed 2014-02-28 |
| 2012-09-30 | $264.25K 10-K · filed 2014-02-28 | $520.65K derived: sum of 2 quarters · filed 2014-02-28 | $901.18K 10-Q · filed 2013-10-25 | $1.30M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-06-30 | $256.41K 10-K · filed 2014-02-28 | $636.93K 10-Q · filed 2013-08-12 | $1.03M derived: sum of 3 quarters · filed 2014-02-28 | $1.38M derived: sum of 4 quarters · filed 2014-02-28 |
| 2012-03-31 | $380.53K 10-K · filed 2014-02-28 | $777.12K derived: sum of 2 quarters · filed 2014-02-28 | $1.13M derived: sum of 3 quarters · filed 2014-02-28 | $1.48M derived: sum of 4 quarters · filed 2014-02-28 |
| 2011-12-31 | $396.59K 10-K · filed 2013-03-26 | $746.94K derived: sum of 2 quarters · filed 2013-03-26 | $1.09M derived: sum of 3 quarters · filed 2013-03-26 | $1.44M 10-K · filed 2013-03-26 |
| 2011-09-30 | $350.35K 10-K · filed 2013-03-26 | $697.92K derived: sum of 2 quarters · filed 2013-03-26 | $1.05M 10-Q · filed 2012-11-14 | $1.35M derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-06-30 | $347.57K 10-K · filed 2013-03-26 | $697.51K 10-Q · filed 2012-08-10 | $995.66K derived: sum of 3 quarters · filed 2013-03-26 | $1.36M derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-03-31 | $349.94K 10-K · filed 2013-03-26 | $648.09K derived: sum of 2 quarters · filed 2013-03-26 | $1.01M derived: sum of 3 quarters · filed 2013-03-26 | $1.32M derived: sum of 4 quarters · filed 2013-03-26 |
| 2010-12-31 | $298.16K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $662.73K derived: sum of 2 quarters · filed 2012-04-16 | $967.43K derived: sum of 3 quarters · filed 2012-04-16 | $1.31M 10-K · filed 2012-04-16 |
| 2010-09-30 | $364.57K 10-Q · filed 2011-11-14 | $669.27K derived: sum of 2 quarters · filed 2011-11-14 | $1.01M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $304.70K 10-Q · filed 2011-08-05 | $646.18K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |